Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Crawford on PSA Testing for Prostate Cancer

E. David Crawford, MD
Published: Tuesday, Mar 07, 2017



E. David Crawford, MD, professor of Radiation Oncology, University of Colorado School of Medicine, discusses challenges facing PSA testing for patients with prostate cancer.

In the future of prostate cancer, it is important to find men who will respond to treatment and not just overtreat them, explains Crawford. Appropriate PSA testing and analysis can help reduce overtreatment.

Crawford simplifies PSA testing by stating that a PSA less than 1.5 is a cutoff point where the patient can return for testing in 5 years, if the PSA is greater than 1.5 then further testing is required.
 


E. David Crawford, MD, professor of Radiation Oncology, University of Colorado School of Medicine, discusses challenges facing PSA testing for patients with prostate cancer.

In the future of prostate cancer, it is important to find men who will respond to treatment and not just overtreat them, explains Crawford. Appropriate PSA testing and analysis can help reduce overtreatment.

Crawford simplifies PSA testing by stating that a PSA less than 1.5 is a cutoff point where the patient can return for testing in 5 years, if the PSA is greater than 1.5 then further testing is required.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x